Source document or public record
FDA 510(k) K201223 — LZI Tramadol Enzyme Immunoassay
FDA 510(k) index record K201223. Device: LZI Tramadol Enzyme Immunoassay. Applicant as listed: Lin-Zhi International, Inc.. Decision date: 2020-06-04.
Source
"device_name": "LZI Tramadol Enzyme Immunoassay"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K201223.
Device name: LZI Tramadol Enzyme Immunoassay. Applicant as listed: Lin-Zhi International, Inc..
Decision date: 2020-06-04. Decision wording: Substantially Equivalent.
Product code: DJG. Regulation: 21 CFR 862.3650. Medical specialty: Clinical Toxicology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.